Microbot Medical Inc [MBOT] stock prices are up 6.96% to $1.23 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The MBOT shares have gain 6.96% over the last week, with a monthly amount drifted -6.11%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 5, February 2024, Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US. In a post published today on Yahoo Finance, The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application.
From an analyst’s perspective:
Microbot Medical Inc [NASDAQ: MBOT] stock has seen the most recent analyst activity on January 13, 2020, when H.C. Wainwright reiterated its Buy rating and also boosted its price target to $26 from $12. Previously, H.C. Wainwright reaffirmed its Buy rating on December 24, 2019, and elevated its price target to $12. On January 31, 2018, Ladenburg Thalmann initiated with a Buy rating and assigned a price target of $1.75 on the stock.
The stock price of Microbot Medical Inc [MBOT] has been fluctuating between $1.00 and $4.37 over the past year. Microbot Medical Inc [NASDAQ: MBOT] shares were valued at $1.23 at the most recent close of the market.
Analyzing the MBOT fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at 12.48, Equity is 15.32 and Total Capital is -1.47. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1567 points at the first support level, and at 1.0833 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.2767, and for the 2nd resistance point, it is at 1.3233.
Microbot Medical Inc [MBOT] reported earnings per share of -$0.21 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.25/share, meaning a difference of $0.04 and a surprise factor of 16.00%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.25 per share as compared to estimates of -$0.31 per share, a difference of $0.06 representing a surprise of 19.40%.
Ratios To Look Out For
It’s worth pointing out that Microbot Medical Inc [NASDAQ:MBOT]’s Current Ratio is 2.09. On the other hand, the Quick Ratio is 2.09, and the Cash Ratio is 0.9.
